Rigel Pharmaceuticals Inc.
RIGL | NASDAQ
$48.06
+$0.97 (+2.06%)
Sep 22, 2026, 1:03 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 78.7M | 58.82M | 69.8M | 69.46M | 101.69M | 53.33M | 57.6M | 55.31M | 36.84M | 29.53M | 35.79M | 28.13M | 26.89M | 26.07M | 51.28M | 22.41M | 29.82M | 16.74M | 20.41M | 21.54M | 26.27M | 81.02M |
Cost of Revenue | 8.53M | 4.61M | 5.96M | 4.75M | 4.5M | 4.41M | 5.79M | 8.03M | 2.81M | 2.03M | 3.79M | 1.27M | 1.08M | 977K | 342K | 250K | 1.04M | 121K | 487K | 151K | 129K | 316K |
Gross Profit | 70.18M | 54.21M | 63.85M | 64.71M | 97.18M | 48.92M | 51.81M | 47.28M | 34.03M | 27.51M | 32M | 26.87M | 25.81M | 25.09M | 50.94M | 22.16M | 28.78M | 16.61M | 19.92M | 21.39M | 26.14M | 80.7M |
Operating Income | 23.58M | 11.89M | 23.17M | 28.42M | 61.1M | 12.77M | 16.66M | 14.06M | 447K | -6.97M | 1.97M | -4.47M | -5.27M | -12.73M | 2.08M | -18.4M | -12.97M | -26.26M | -21.42M | -19.79M | -13.05M | 41.76M |
Interest Income | 789K | 1.21M | 1.24M | 1.09M | 753K | 591K | 522K | 425K | 552K | 593K | 678K | 672K | 529K | 393K | 429K | 192K | 42K | 21K | 16K | 14K | 16K | 1K |
Pretax Income | 23.59M | 11.66M | 22.71M | 27.62M | 59.98M | 11.51M | 15.22M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M | -13.54M | 1.4M | -19.04M | -13.49M | -27.45M | -22.7M | -21.09M | -14.79M | 41.27M |
Net Income | 17.29M | 8.65M | 268.07M | 27.9M | 59.61M | 11.45M | 14.34M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M | -13.54M | 1.4M | -19.04M | -13.49M | -27.45M | -22.64M | -20.95M | -13.82M | 39.5M |
Selling & General & Admin | 32.64M | 30.65M | 29.99M | 28.94M | 29.26M | 27.72M | 29.52M | 27.04M | 28.05M | 28.45M | 26.85M | 24.86M | 26.31M | 27.73M | 32.17M | 25.9M | 26.98M | 27.4M | 24.52M | 22.88M | 22.38M | 22.12M |
Research & Development | 13.96M | 11.68M | 10.69M | 7.35M | 6.82M | 8.44M | 5.63M | 6.18M | 5.54M | 6.03M | 3.19M | 6.48M | 4.77M | 10.09M | 15.37M | 14.67M | 14.77M | 15.47M | 13.3M | 18.3M | 16.81M | 16.83M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.32M | n/a | n/a | n/a | 3.52M | n/a | n/a | n/a |
Operating Expenses | 46.6M | 42.33M | 40.68M | 36.29M | 36.08M | 36.15M | 35.15M | 33.23M | 33.59M | 34.48M | 30.04M | 31.33M | 31.08M | 37.82M | 48.86M | 40.56M | 41.75M | 42.88M | 41.34M | 41.18M | 39.19M | 38.95M |
Interest Expense | 779K | 1.43M | 1.7M | 1.89M | 1.87M | 1.85M | 1.96M | 2.06M | 2.03M | 1.87M | 1.91M | 1.9M | 1.86M | 1.2M | 1.11M | 826K | 569K | 1.21M | 1.3M | 1.32M | 1.76M | 485K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 544K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 55.13M | 46.93M | 46.63M | 41.04M | 40.58M | 40.56M | 40.94M | 41.25M | 36.39M | 36.5M | 33.83M | 32.6M | 32.15M | 38.8M | 49.2M | 40.81M | 42.78M | 43M | 41.83M | 41.33M | 39.31M | 39.26M |
Income Tax Expense | 6.3M | 3M | -245.35M | -280K | 369K | 65K | 881K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -60K | -136K | -970K | 1.77M |
Shares Outstanding (Basic) | 18.54M | 18.41M | 17.99M | 18.04M | 17.89M | 17.81M | 17.65M | 17.6M | 17.55M | 17.52M | 17.45M | 17.44M | 17.36M | 17.36M | 17.29M | 17.28M | 17.21M | 17.18M | 17.11M | 17.09M | 17.02M | 16.98M |
Shares Outstanding (Diluted) | 19.57M | 19.69M | 18.84M | 19.16M | 18.16M | 18.17M | 17.99M | 17.65M | 17.55M | 17.52M | 17.45M | 17.44M | 17.36M | 17.36M | 17.29M | 17.28M | 17.21M | 17.18M | 17.11M | 17.09M | 17.02M | 17.61M |
EPS (Basic) | 0.93 | 0.47 | 14.72 | 1.55 | 3.33 | 0.64 | 0.81 | 0.71 | -0.06 | -0.47 | 0.04 | -0.33 | -0.38 | -0.80 | 0.10 | -1.10 | -0.80 | -1.60 | -1.30 | -1.20 | -0.80 | 2.30 |
EPS (Diluted) | 0.88 | 0.44 | 13.54 | 1.46 | 3.28 | 0.63 | 0.80 | 0.70 | -0.06 | -0.47 | 0.04 | -0.33 | -0.38 | -0.80 | 0.10 | -1.10 | -0.80 | -1.60 | -1.30 | -1.20 | -0.80 | 2.20 |
EBITDA | 24.36M | 13.69M | 25.01M | 30.12M | 62.46M | 13.97M | 17.78M | 15.09M | 1.61M | -5.97M | 2.94M | -3.5M | -4.44M | -11.98M | 2.79M | -17.97M | -12.69M | -26M | -21M | -19.51M | -12.77M | 42M |
EBIT | 24.36M | 13.09M | 24.41M | 29.51M | 61.86M | 13.36M | 17.18M | 14.48M | 999K | -6.37M | 2.64M | -3.79M | -4.74M | -12.33M | 2.51M | -18.21M | -12.92M | -26.24M | -21.4M | -19.77M | -13.03M | 41.76M |
Depreciation & Amortization | n/a | 597K | 601K | 603K | 607K | 604K | 604K | 611K | 613K | 400K | 293K | 292K | 296K | 357K | 284K | 240K | 237K | 237K | 404K | 261K | 258K | 239K |
Add to Watchlist
Select watchlists to add or remove RIGL